[CITATION][C] Ruxolitinib as first‐line treatment in secondary hemophagocytic lymphohistiocytosis: a second experience
I Zandvakili, CB Conboy, AO Ayed… - American journal of …, 2018 - Wiley Online Library
I Zandvakili, CB Conboy, AO Ayed, EJ Cathcart‐Rake, A Tefferi
American journal of hematology, 2018•Wiley Online Library[1] Mancini M, Hasan SK, Ottone T, et al. Two novel methods for rapid detection and
quantification of DNMT3A R882 mutations in acute myeloid leukemia. J Mol Diagn. 2015; 17
(2): 179–184.[2] Pløen GG, Nederby L, Guldberg P, et al. Persistence of DNMT3A mutations
at long-term remission in adult patients with AML. Br J Haematol. 2014; 167 (4): 478–486.[3]
Angelini DF, Ottone T, Guerrera G, et al. A Leukemia-associated CD34/CD123/CD25/CD991
immunophenotype identifies FLT3-mutated clones in acute myeloid leukemia. Clin Cancer …
quantification of DNMT3A R882 mutations in acute myeloid leukemia. J Mol Diagn. 2015; 17
(2): 179–184.[2] Pløen GG, Nederby L, Guldberg P, et al. Persistence of DNMT3A mutations
at long-term remission in adult patients with AML. Br J Haematol. 2014; 167 (4): 478–486.[3]
Angelini DF, Ottone T, Guerrera G, et al. A Leukemia-associated CD34/CD123/CD25/CD991
immunophenotype identifies FLT3-mutated clones in acute myeloid leukemia. Clin Cancer …
[1] Mancini M, Hasan SK, Ottone T, et al. Two novel methods for rapid detection and quantification of DNMT3A R882 mutations in acute myeloid leukemia. J Mol Diagn. 2015; 17 (2): 179–184.[2] Pløen GG, Nederby L, Guldberg P, et al. Persistence of DNMT3A mutations at long-term remission in adult patients with AML. Br J Haematol. 2014; 167 (4): 478–486.[3] Angelini DF, Ottone T, Guerrera G, et al. A Leukemia-associated CD34/CD123/CD25/CD991 immunophenotype identifies FLT3-mutated clones in acute myeloid leukemia. Clin Cancer Res. 2015; 21 (17): 3977–3985.
Wiley Online Library